Literature DB >> 34316386

Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using Diagnostic Codes.

Nasibeh Zanjirani Farahani1, Shivaram Poigai Arunachalam2, Divaakar Siva Baala Sundaram3, Kalyan Pasupathy1, Moein Enayati1, Adelaide M Arruda-Olson4.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic heart disease that is the leading cause of sudden cardiac death (SCD) in young adults. Despite the well-known risk factors and existing clinical practice guidelines, HCM patients are underdiagnosed and sub-optimally managed. Developing machine learning models on electronic health record (EHR) data can help in better diagnosis of HCM and thus improve hundreds of patient lives. Automated phenotyping using HCM billing codes has received limited attention in the literature with a small number of prior publications. In this paper, we propose a novel predictive model that helps physicians in making diagnostic decisions, by means of information learned from historical data of similar patients. We assembled a cohort of 11,562 patients with known or suspected HCM who have visited Mayo Clinic between the years 1995 to 2019. All existing billing codes of these patients were extracted from the EHR data warehouse. Target ground truth labeling for training the machine learning model was provided by confirmed HCM diagnosis using the gold standard imaging tests for HCM diagnosis echocardiography (echo), or cardiac magnetic resonance (CMR) imaging. As the result, patients were labeled into three categories of "yes definite HCM", "no HCM phenotype", and "possible HCM" after a manual review of medical records and imaging tests. In this study, a random forest was adopted to investigate the predictive performance of billing codes for the identification of HCM patients due to its practical application and expected accuracy in a wide range of use cases. Our model performed well in finding patients with "yes definite", "possible" and "no" HCM with an accuracy of 71%, weighted recall of 70%, the precision of 75%, and weighted F1 score of 72%. Furthermore, we provided visualizations based on multidimensional scaling and the principal component analysis to provide insights for clinicians' interpretation. This model can be used for the identification of HCM patients using their EHR data, and help clinicians in their diagnosis decision making.

Entities:  

Keywords:  billing code; classification; decision making; diagnostic codes; electronic health records (EHR); hypertrophic cardiomyopathy (HCM); machine learning; random forest

Year:  2021        PMID: 34316386      PMCID: PMC8313105          DOI: 10.1109/bibm49941.2020.9313231

Source DB:  PubMed          Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)        ISSN: 2156-1125


  9 in total

1.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 2.  Clinical Course and Management of Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron
Journal:  N Engl J Med       Date:  2018-08-16       Impact factor: 91.245

Review 3.  Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron; Ethan J Rowin; Martin S Maron
Journal:  Circ Res       Date:  2019-08-01       Impact factor: 17.367

4.  Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Shibani M Kudchadkar; Gabriela Villarreal Greenland; Prasanth Lingamaneni; Celia P Corona-Villalobos; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan Zimmerman; Theodore P Abraham; Hagit Shatkay; Maria Roselle Abraham
Journal:  Am J Cardiol       Date:  2019-02-27       Impact factor: 2.778

5.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.

Authors:  Mar Pujades-Rodriguez; Oliver P Guttmann; Arturo Gonzalez-Izquierdo; Bram Duyx; Constantinos O'Mahony; Perry Elliott; Harry Hemingway
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

7.  Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes.

Authors:  Peter Magnusson; Andreas Palm; Eva Branden; Stellan Mörner
Journal:  Clin Epidemiol       Date:  2017-08-09       Impact factor: 4.790

8.  Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.

Authors:  Christopher M Kramer; Evan Appelbaum; Milind Y Desai; Patrice Desvigne-Nickens; John P DiMarco; Matthias G Friedrich; Nancy Geller; Sarahfaye Heckler; Carolyn Y Ho; Michael Jerosch-Herold; Elizabeth A Ivey; Julianna Keleti; Dong-Yun Kim; Paul Kolm; Raymond Y Kwong; Martin S Maron; Jeanette Schulz-Menger; Stefan Piechnik; Hugh Watkins; William S Weintraub; Pan Wu; Stefan Neubauer
Journal:  Am Heart J       Date:  2015-05-22       Impact factor: 4.749

9.  Billing code algorithms to identify cases of peripheral artery disease from administrative data.

Authors:  Jin Fan; Adelaide M Arruda-Olson; Cynthia L Leibson; Carin Smith; Guanghui Liu; Kent R Bailey; Iftikhar J Kullo
Journal:  J Am Med Inform Assoc       Date:  2013-10-28       Impact factor: 4.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.